Cardisure 3.5mg/mL Oral Solution - 168ml
Dechra |
APPIM168

Cardisure 3.5mg/mL Oral Solution - 168ml

Prescription Product

This is a Schedule 4 (S4) Controlled Substance. Supply is strictly regulated under Australian law. Valid authorisation is required to purchase this product.

Enquire today to create an account

Register
Description
Indicated for the treatment of canine congestive heart failure (CHF) originating from dilated cardiomyopathy (DCM) or valvular insufficiency (mitral and/or tricuspid regurgitation). The treatment of preclinical DCM in large breed dogs.

Active(s): Pimobendan 3.5mg/ml

Pack size: 168ml
Additional Information
[Zebravet_Files]:
[Zebravet_Files]
Classification:
S4
Species:
Dog
Ingredients:
Pimobendan